Bitter taste receptors (TAS2Rs) are expressed on human airway smooth muscle (HASM) and evoke marked relaxation. Agonist interaction with TAS2Rs activates phospholipase C and increases compartmentalized intracellular Ca 21 ([Ca 21 ] i ) via inositol 1,4,5 triphosphate. In taste cells, the G protein gustducin couples TAS2R to phospholipase C; however, we find very low levels of G agust mRNA or protein in HASM. We hypothesized that another G protein in HASM transmits TAS2R function. TAS2R signaling to [Ca 21 ] i , extracellular signal-regulated kinase (ERK) 1/2, and physiologic relaxation was sensitive to pertussis toxin, confirming a role for a member of the G i family. a subunit expression in HASM was G ai2 . G ai1 = G ai3 . G atrans1 G atrans2 , with G agust and G ao at the limits of detection (.100-fold lower than G ai2 ). Small interfering RNA knockdowns in HASM showed losses of [Ca 21 ] i and ERK1/2 signaling when G ai1 , G ai2 , or G ai3 were reduced. G atrans1 and G atrans2 knockdowns had no effect on [Ca 21 ] i and a minimal, transient effect on ERK1/2 phosphorylation. Furthermore, G agust and G ao knockdowns did not affect any TAS2R signaling. In overexpression experiments in human embryonic kidney-293T cells, we confirmed an agonistdependent physical interaction between TAS2R14 and G ai2 . ASM cells from transgenic mice expressing a peptide inhibitor of G ai2 had attenuated relaxation to TAS2R agonist. These data indicate that, unlike in taste cells, TAS2Rs couple to the prevalent G proteins, G ai1 , G ai2 , and G ai3 , with no evidence for functional coupling to G agust . This absence of function for the "canonical" TAS2R G protein in HASM may be due to the very low expression of G agust , indicating that TAS2Rs can optionally couple to several G proteins in a cell type-dependent manner contingent upon G protein expression.
Unexpectedly, bitter taste receptors have been localized on airway smooth muscle. These G protein-coupled receptors are activated by a variety of natural and synthetic compounds, resulting in smooth muscle relaxation, thus pointing toward a new class of direct bronchodilators for asthma and chronic obstructive pulmonary disease. A puzzle in the signal transduction cascade for these extraoral receptors is what G protein they use to transmit agonist binding to effector activation. We show here that in airway smooth muscle they do not functionally use the canonical bitter taste receptor G protein G agust but instead use G ai1 , G ai2 , and G ai3 . These findings now provide for a methodical approach for drug discovery and consideration of whether pathologic processes that modify these G ai proteins could alter therapeutic effectiveness.
Bitter taste receptors (TAS2Rs) have been traditionally thought to be expressed on taste cells of the tongue, signaling to the brain as part of a system to avoid ingestion of toxic plants (1, 2) . These receptors are members of the superfamily of cell surface G protein-coupled receptors (GPCRs). Over the last few years, we and others have demonstrated expression of certain TAS2R subtypes on airway smooth muscle (ASM) of human (3) , monkey (4), mouse (3) , and guinea pig (5) . Activation of TAS2Rs on ASM results in profound relaxation and bronchodilation by a non-cAMP mechanism (3, 6) . This action represents a new pathway for development of direct bronchodilators for the treatment of obstructive lung disease. The three highest expressing TAS2R subtypes in human ASM (HASM) are TAS2R10, -14, and -31. Like other GPCRs, TAS2Rs carry out signaling by coupling to G proteins with subsequent activation of an effector enzyme. The TAS2Rs of taste cells (1) have been shown to couple to the G protein, gustducin; agonist activation and coupling results in the dissociation of the a subunit (G agust ) and the bg subunits, with bg activating phospholipase C (PLC), generating inositol 1,4,5 triphosphate (IP 3 ). IP 3 binding to its receptor on the endoplasmic reticulum releases intracellular Ca 21 ([Ca 21 ] i ), which subsequently activates a transient receptor potential channel, increasing Na 1 influx. This influx depolarizes the cell membrane, causing release of neurotransmitter, which stimulates the adjacent type III taste cell to communicate to the central nervous system.
The pathway diverges in ASM at the IP 3 and/or [Ca 21 ] i release steps (3) . In HASM cells, membrane potential hyperpolarizes, whereas it depolarizes in taste cells. Indeed, agonists of other GPCRs that increase [Ca 21 ] i in HASM, such as acetylcholine, histamine, and leukotrienes, lead to membrane depolarization and smooth muscle contraction, as opposed to the increase in [Ca 21 ] i evoked by TAS2R agonists that causes hyperpolarization and relaxation. Studies to date have indicated that the [Ca 21 ] i released from TAS2Rs resides in a specialized compartment, which differs from the more global increase in [Ca 21 ] i observed with contractile GPCRs (3) . Recent data also indicate that IP 3 production is more restricted than previously thought (7), providing additional signaling plasticity by different receptors. Multiwell plate-based fluorescence readers, such as used for this and most TAS2R signaling studies, accurately quantitate [Ca 21 ] i even though it may be somewhat localized within the cell.
TAS2Rs have now also been reported to be expressed in a number of other extraoral tissues, including stomach, colon, thyroid, brain, and white blood cells, where pharmacologic activation results in multiple biologic actions (8) . The presumption has been with ASM, as well as these other tissues, that TAS2R function occurs by receptor coupling to gustducin. However, the expression of this taste receptor G protein is very low, and indeed difficult to detect at the protein or mRNA levels in HASM and some of these other tissues, compared with taste cells, where it is abundant. Gustducin is a member of the "G i family" of G protein a subunits, which includes G ai1 , G ai2 , G ai3 , G ao , and G az , and the transducins (the visual G proteins), G atrans1 and G atrans2 . Some of these G proteins within this family share a high degree of sequence identity, and, given the very low levels of expression of G agust in HASM, we have undertaken the task of ascertaining which of the G i family of G proteins carries out signal transduction of TAS2Rs in HASM. We hypothesized that one or more other members of this family that are abundantly expressed in these cells are responsible for TAS2R functional coupling in HASM.
Materials and Methods

Cell Culture and Transfections
Human embryonic kidney-293T (HEK-293T), primary HASM (passages 3-8; Lonza, Basel, Switzerland), and the D9 human telomerase reverse transcriptase immortalized HASM cells (D9 hTERT) (9) were grown as previously described (9, 10) . In some experiments, cells were treated with pertussis toxin (PTX) at the indicated concentrations in media for 24 hours. For Ga subunit knockdowns, HASM cells were transfected with 100 mM of small interfering RNAs (siRNAs) 24 hours and again 48 hours after plating using lipofectamine 2000 (Invitrogene, Carlsbad, CA). The siRNAs are shown in Table E1 in the online supplement. Transfections with cDNAs encoding TAS2R14 and G ai2 were performed in HEK-293T (10).
Western Blots and Quantitative RT-PCR
To detect G i a subunit protein expression, SDS-PAGE and Western blots were performed using solubilized whole-cell lysates exactly as previously described (10) using primary antibodies and titers listed in Table E2 and subsequent secondary antibody at a titer of 1:10,000 for chemoluminescence (Thermo Scientific, Waltham, CA) with detection using the ChemiDoc MP (Bio-Rad, Hercules, CA). Bands were quantitated using the provided software or Image-J (National Institutes of Health, Bethesda, MD). Quantitative RT-PCR was performed on HASM RNA using methods exactly as previously described (3). The primers were from Applied Biosystems (Foster City, CA; Table E3 ). Comparisons were made using the 2 2DCT method where DC T is the difference in C T values between the transcript of interest and that of glyceraldehyde 3-phosphate dehydrogenase. ] i responses from multiple experiments. For extracellular signal-regulated kinase (ERK) 1/2 activation studies, cells were serum starved for 18 hours, treated with vehicle or agonist, and SDS-PAGE and Western blots were performed using antibodies (Table E1) for total ERK1/2 and phospho-ERK1/2 with previously described methods (10, 11) .
Receptor-Ga Interaction cDNA constructs encoding TAS2R14 and G ai2 were cotransfected transiently into HEK-293 cells using lipofectamine 2000. After 48 hours, cells were exposed to 500 mM DPD for the indicated time followed by treatment with a membrane-permeant cross-linking reagent (dithiobis (succinimidyl propionate); 1 mM) for 30 minutes in non-aminecontaining buffer. Excess cross-linker was quenched in 25 mM Tris (pH 7.4) for 15 minutes at room temperature, and cells were lysed in 0.1% CHAPS buffer, followed by coimmunoprecipitation, as described previously (10) .
Magnetic Twisting Cytometry
These studies were performed as previously described (12, 13) . Briefly,
ORIGINAL RESEARCH
Ary-Gly-Asp-coated ferrimagnetic beads were bound to cell surface integrin receptors on ASM cells. The beads are magnetized horizontally and twisted in a vertically aligned magnetic field. Bead displacement measures the increase or decrease in the twist in individual cells, corresponding to contraction and relaxation, respectively.
Genomic and Statistical Analysis
Human G i family a subunits were aligned using the alignment program COBALT and the identity matrix values were calculated using blastp within BLAST (all programs are from the National Institutes of Health).
Results from biochemical studies are presented as mean (6SE) of the indicated number of experiments. Comparisons were performed by paired or unpaired two-sided t tests, with significance imparted at P less than 0.05. Magnetic twisting cytometry results were analyzed by a nested ANOVA (14) . 1B ). Additional studies were also performed using phosphorylation of ERK1/2 as the signal readout. The early increase in phospho-ERK1/2 from GPCR activation (z5-10 min of agonist exposure) is due to receptor G protein interaction. Responses at the 30-minute time point are b-arrestin dependent and relatively independent of G protein interaction (15, 16) . We thus expected that the 5-and 10-minute signals would be blocked by PTX pretreatment if coupling was by one or more G ai subunits. As shown in Figures 1C and 1D , DPD exposure resulted in marked phosphorylation of ERK1/2 in the primary HASM cells, which was inhibited approximately 85% by PTX pretreatment. Similar results were observed in the immortalized HASM ( Figures 1E and 1F ). Finally, we examined a physiologic response of HASM, using magnetic twisting cytometry. As previously described, TAS2R agonists cause a decrease in twisting force ("relaxation") in HASM (3, 13) . Figure 1G shows that the DPD-promoted decrease in twisting force was markedly attenuated by PTX pretreatment. Taken together, these data confirm that the biochemical and physiologic responses to agonist by TAS2Rs in HASM cells are transduced via one or more members of the PTX-sensitive G proteins of the G i family.
Results
TAS2R
Expression of the G i Family of a Subunits in HASM
We ascertained both mRNA and protein expression of the eight a subunits. Figure 2A shows the mRNA expression in HASM using quantitative RT-PCR and is expressed as 2
2DCt
, where DCt is defined as the difference between Ct values of the given G protein a subunit and glyceraldehyde 3-phosphate dehydrogenase. By far the most abundant mRNAs of this class in HASM are G ai1 , G ai2 , and G ai3 , being more than 5,000-fold greater than G agust . Indeed, G agust mRNA expression was quite low (C T values z30), G ao was typically below the limits of detection, and G az transcripts were not detected or were very low. G atrans2 mRNA levels were reliably detected, but were still several hundred fold less than any of the G ai transcripts, whereas G atrans1 transcripts were minimally detected ( Figure 2A) . Overall, the pattern of the mRNA levels of these G ai subunits was the same between primary HASM cells and the D9 hTERT immortalized HASM line ( Figure 2A ). For comparison of the protein expression levels, we encountered low expression of some of the a subunits. Thus, in Figure 2B , we show the long exposure times from the images for representative Western blots for G agust , G ao , and G az . As indicated, G ai1 , G ai2 , and G ai3 were the most abundantly expressed at the protein level, whereas expression levels of G agust , G ao , and G az were very low. G atrans1 and G atrans2 were expressed at intermediate levels compared with the others in the group. Figure 2C shows results from multiple experiments, normalized to b-actin, and provides a semiquantitative assessment of G ai family a subunit protein expression in HASM cells. The mRNA and protein data are congruent except for G atrans1 , where we observe protein expression, but little mRNA expression in either cell line. Taken together, though, the results of these expression studies indicate that G ai1 , G ai2 , and G ai3 are the dominant G i protein a subunits in HASM, with intermediate levels of G atrans1 and G atrans2 protein expression. G agust expression was very low, whereas G ao and G az were inconsistently detected at the very low level. (Figure 3C ), but the effect was not additive.
Representative ERK1/2 experiments are shown in Figure 4A . Due to low or nonexistent expressions, G ao and G az knockdown experiments were not performed. As can be seen, knockdown of any of the G ai subunits caused a decrease in DPD-stimulated phosphorylation of ERK1/2 at the 5-and 10-minute time points ( Figure 4B ). From these data, we cannot define, in absolute terms, which is the "preferred" G ai subunit for TAS2R signal transduction, because the siRNAs reduced G ai proteins to different levels ( Figure 4A ). However, it is nevertheless clear that each of these highly expressed subunits contributes to TAS2R coupling to this pathway. For the transducins, we observed a small decrease in phospho-ERK1/2 at the 5-minute, but not at the 10-minute, time point with knockdown of either G atrans1 or G atrans2 (Figures 4A and 4B) . Knockdown of G agust had no effect on agonist-promoted phosphorylation of ERK1/2. As indicated in the above studies, each of the G ai subunits appears to be capable of transducing TAS2R signaling to [Ca 21 ] i or ERK1/2. Given that G ai2 has roughly 68% amino acid identity with the canonical TAS2R G protein, gustducin (Table 1) , we performed experiments to confirm that G ai2 can indeed directly interact with TAS2R14 (the receptor for DPD) in an agonist-dependent manner. HEK-293T cells were transfected with G ai2 and FLAG-tagged TAS2R14. After 48 hours, the cells were exposed to vehicle or the agonist, DPD, and, 3 minutes later, the cells were treated with the cross-linking agent, dithiobis (succinimidyl propionate). The cross-linking step was used to ensure that any physical coupling between G protein and receptor was not lost during the subsequent coimmunoprecepitation steps. The cells were then solubilized, immunoprecipitated with FLAG antibody, and the precipitate subjected to SDS-PAGE and Western blotting with anti-G ai2 antibody. As shown in Figure 5 , the coimmunoprecipitation signal was increased when cells were treated with the agonist, consistent with agonist-promoted physical coupling of the receptor to this G protein a subunit.
Signaling and
Physiologic Effects of Overexpressing G ai2 and Its Peptide Inhibitor on TAS2R14 Function in ASM The above results lead us to explore TAS2R signaling with previously constructed transgenic mouse ASM cell lines overexpressing G ai2 (G ai2 OE) or expressing a G ai2 inhibitory peptide (G ai2 IP). ASM cells derived from nontransgenic (NTG) littermates were used as controls. In transgenic G ai2 IP ASM, DPD-mediated [Ca
21
] i signaling was significantly attenuated by over 50% compared with NTG cells (Figures 6A and 6B) . These results are consistent with the knockdown studies shown in Figure 3B . In the transgenic G ai2 OE ASM, DPD-mediated [Ca 21 ] i signaling was enhanced by roughly twofold. The results of TAS2R-mediated phosphorylation of ERK1/2 in these cells are shown in Figures 6C and 6D , and revealed a decrease in this signal in G ai2 IP cells and a modest increase in the G ai2 OE cells. To ascertain the physiologic consequences of this altered functional coupling to G ai2 , we used magnetic twisting cytometry ( Figure 6E ). Cells were twisted (contracted) with endothelin-1 or 5-hydroxytryptamine. NTG mouse ASM displayed approximately 35% decrease in cell stiffness (relaxation) upon TAS2R14 activation. In contrast, cells expressing the G ai2 IP showed little or no change in TAS2R-mediated stiffness, consistent with depressed coupling between the receptor and native G ai . However, the G ai2 OE mouse ASM showed a decrease in stiffness with TAS2R14 activation that was not different than NTG.
Discussion
The typical therapeutic agents for treating asthma and chronic obstructive pulmonary disease are corticosteroids to reduce inflammation, and direct and indirect bronchodilators for treating airway obstruction. Indirect bronchodilators (17, 18) are antagonists for receptors (such as the M 3 -muscarinic) that contract ASM, which are activated by local increases 
α t r a n s 1 G α t r a n s 2 The treatment response to b-agonists, however, is associated with significant interindividual variability and a number of unfavorable outcomes (19) (20) (21) (22) (23) (24) (25) .
We have undertaken a systematic approach to identify and characterize HASM G protein-coupled receptors to find other pathways that act to constrict or dilate airways, so as to consider additional receptors for therapeutic development (26) . Unexpectedly, we found expression of multiple TAS2Rs on HASM, with 6 of the 25 human subtypes expressed at levels greater than the b 2 AR (3). Agonists for these TAS2Rs evoked marked relaxation of HASM in ex vivo studies, single-cell measurements, and an in vivo murine model of asthma (3). These findings have led to considering TAS2R agonists as therapy for obstructive lung diseases, either as primary agents or in addition to b-agonists (17, 27) . Ongoing studies have used high-throughput screening and medicinal chemistry to identify agonists with high affinity and selectivity (2) . Subsequently, TAS2Rs have been identified on cell types in other organs, indicating a previously unrecognized chemosensory system in the body that has a broad range of physiologic and pathologic implications, and also represents new avenues for drug development (8) . Of concern in understanding TAS2R signaling in extraoral tissues is the very low expression of G agust found in most of these cell types. Although it is now recognized that GPCRs can couple to more than one G protein, this is typically in the setting of abundantly expressed G proteins (28, 29) . In terms of non-taste cell TAS2Rs, such as those on HASM, the presumed canonical G protein is at the limit of detection by quantitative RT-PCR and Western blots, suggesting that the main transducer of TAS2R signaling in HASM is not G agust . Because of the degree of amino acid identity (Table 1) , and the sensitivity of the biochemical and physiological responses of TAS2R activation in HASM to PTX, we hypothesized that one or more members of the G i family, which are abundantly expressed in HASM, carries out signal transduction from receptor to effector in this cell type. Here, we show that, in ASM, the G ai1,2,3 subfamily clearly carries out TAS2R signal transduction, with no measurable contribution from G agust . This is most likely due to the fact that these G ai subunits have the capacity to couple to TAS2Rs (as we show here), and that the low expression of G agust , which we also know couples to TAS2Rs, in essence minimizes any potential functional relevance of this G protein in this particular cell type. The transducins, which have even greater amino acid identity with gustducin than G ai1,2,3 (Table 1) , also appear to play a minor role, at least in signaling to ERK1/2. The lower expression levels of the transducins may also be the basis for its minor role in TAS2R signaling in HASM, as we also know that these G proteins can couple to TAS2Rs (30) . The fact that the ERK1/2 pathway, but not the [Ca 21 ] i pathway, was affected by transducin knockdowns is a phenomenon observed in other multidimensional signaling systems. It may be related to different levels of signaling amplification that are present between two pathways, such that there are spare receptor G protein units for one pathway versus another (31) . This also illustrates the advantages of the knockdown strategy we used here as compared with simply overexpressing a given a subunit, which could lead to either promiscuous coupling or saturation. Indeed, we did not observe an increase in ASM relaxation to TAS2R agonist in the mouse ASM G ai2 OE cells (Figure 6E ), probably because of the abundance of this a subunit in ASM cells in the native state.
We have previously shown that TAS2R signaling is sensitive to gallein (which sequesters the G bg subunit) and PLC inhibitors (3) . Taken together with the current data, it is clear that G bg released from a heterodimer composed of G ai1 , G ai2 , or G ai3 a subunits carries out the majority of TAS2R signaling in HASM, and, indeed, multiple G bg subunit combinations found in G i heterodimers have been shown to stimulate PLC (32, 33) . It is recognized that G protein a subunits are dynamically regulated by multiple pathologic events, and we can now place the relevance of such changes into the context of TAS2R agonist treatment of obstructive airways disease. G ai2 (and/or G ai1 and G ai3 ) is increased in various animal or cell models of bronchial hyperresponsiveness, airway inflammation, and asthma (11, (34) (35) (36) (37) (38) . This increase has also been shown to decrease b-agonist bronchodilator responsiveness, because b 2 ARs also couple to G ai , and thus attenuate receptor-activated adenylyl cyclase (11) . However, this increase in G ai would not be expected to affect TAS2R function, and may even enhance it, given that this subfamily is responsible for the ASM relaxation response to TAS2R activation. Chronic activation of some G i -coupled receptors has been shown to down-regulate cellular levels of G ai protein. For example, with the a 2A AR, stably transfected and natively expressing cells display approximately 40% loss of G ai2 after 24 hours of exposure to high (saturating) concentrations of receptor agonist (39, 40) . There are many G i -coupled receptors expressed on HASM (26) , and it is conceivable that prolonged exposure to certain locally produced substances in pathologic states, such as asthma or chronic obstructive pulmonary disease, might result in G ai down-regulation. Although we are not aware of such decreases, this particular scenario might lead to a reduction of the effectiveness of TAS2R agonists in relaxing ASM. Even a complete loss of one of these subunits, however, would not be expected to result in total loss of TAS2R function, because G ai1 , G ai2 , and G ai3 all appear to be capable of transmitting TAS2R activation in HASM.
In the taste field, G agust has been considered the primary G protein for TAS2Rs; however, there is evidence within several studies that suggest alternative coupling. G agust knockout mice retain some sensitivity to bitter tastants, suggesting that one or more additional G proteins in taste cells may provide for coupling (41) . Given the high degree of homology between gustducin and transducin (Table 1) , a transgenic mouse was developed overexpressing G atrans1 on the G agust null background. Bitter taste responsiveness in this mouse was partially, but not fully, restored, which suggested that G atrans1 can substitute for G agust , but expression levels or heterogeneity of transgene expression may have limited rescue (30) . In other studies, where single-cell recordings were undertaken, in some cells there was actually no difference in TAS2R signaling by some agonists between G agust (2) and G agust (1) cells, again pointing to alternative G proteins that can functionally couple to TAS2Rs (42) . Taken together with the current work, where G agust expression in HASM is very low, it may be the case that any of several G i family a subunits will couple to TAS2Rs, and that the principal TAS2R-activated G protein in a given cell type is based primarily on expression levels. As indicated in Table 1 and the amino acid sequence alignment in Figure E1 , one can readily group these eight G proteins into several subfamilies. G atrans1 and G atrans2 show the greatest homology to G agust (78 and 80%, respectively). G ai1 , G ai2 , and G ai3 are highly similar to each other, and are 68% identical to G agust . Given our results, and the locations of the differences in amino acid sequences between this group and G agust (43) ( Figure  E1 ), this degree of homology appears to be adequate for TAS2R coupling. Although G ao has some degree of sequence identity to G ai1 , G ai2 , and G ai3 , the identity to G agust is 62%. A similar comparison is apparent for G az , with identity to G agust being 58%. It thus seems less likely that G ao and G az participate in TAS2R signaling in HASM due to this lower amino acid similarity to G agust , the low protein expression of these subunits, and the PTX insensitivity, which excludes G az . Regardless, our goal for this study was not to determine the "affinities" of the eight a subunits for coupling to TAS2Rs, but rather to ascertain which of these a subunits are pertinent for TAS2R signaling in HASM. We show that, in this cell type, unlike that of the taste cell, G ai1 , G ai2 , and G ai3 are the principal G proteins to which TAS2Rs couple to intracellular signaling and relaxation. n 
